Search research articles
Contact Us
Filters
Showing results (281-290 of 317) with videos related to
Page
of 32
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 26, 2021
Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive Cohort
Rafal Dziadziuszko, Tony Mok, Solange Peters, et al.
The Lancet. Oncology
|
June 12, 2021
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, et al.
JCO Precision Oncology
|
October 14, 2022
Clinical and Genomic Features of <i>HER2</i> Exon 20 Insertion Mutations and Characterization of <i>HER2</i> Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer
Aaron C Tan, Stephanie P L Saw, Jianbin Chen, et al.
Cancer
|
February 29, 2024
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer
Aaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC
Aaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 28, 2026
Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC - A Delphi study by the Asian Thoracic Oncology Research Group (ATORG)
Aaron C Tan, Bin-Chi Liao, Molly Li, et al.
JCO Global Oncology
|
August 22, 2022
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations
Christian Caglevic, Christian Rolfo, Ignacio Gil-Bazo, et al.
Nature Communications
|
September 7, 2017
Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time
Shumei Chia, Joo-Leng Low, Xiaoqian Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2022
Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
F Griesinger, G Curigliano, M Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2024
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Tanya Dorff, Lisa G Horvath, Karen Autio, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 317) with videos related to
Sort By:
Page
of 32
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 26, 2021
Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive Cohort
Rafal Dziadziuszko, Tony Mok, Solange Peters, et al.
The Lancet. Oncology
|
June 12, 2021
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, et al.
JCO Precision Oncology
|
October 14, 2022
Clinical and Genomic Features of <i>HER2</i> Exon 20 Insertion Mutations and Characterization of <i>HER2</i> Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer
Aaron C Tan, Stephanie P L Saw, Jianbin Chen, et al.
Cancer
|
February 29, 2024
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer
Aaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC
Aaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 28, 2026
Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC - A Delphi study by the Asian Thoracic Oncology Research Group (ATORG)
Aaron C Tan, Bin-Chi Liao, Molly Li, et al.
JCO Global Oncology
|
August 22, 2022
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations
Christian Caglevic, Christian Rolfo, Ignacio Gil-Bazo, et al.
Nature Communications
|
September 7, 2017
Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time
Shumei Chia, Joo-Leng Low, Xiaoqian Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2022
Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
F Griesinger, G Curigliano, M Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2024
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Tanya Dorff, Lisa G Horvath, Karen Autio, et al.
Page
of 32